Solebury Trout
Industry Snippets: September 2018 Sell-Side Update
Solebury Trout

 

In September, there was moderate analyst turnover, with a notable return of Yaron Werber to the sell-side, leaving Ovid Therapeutics to return to Cowen. Werber joined Ovid from Citi in 2015, after spending nearly 15 years as a biotechnology research analyst at Cowen and Citi. Wolfe Research and Stephens continue to expand their research teams. Quite a few analysts released initiations of their coverage universes following their transitions to new firms, including Derek Archila (Stifel), Andrew Berens (Leerink), Michael Schmidt (Guggenheim), as well as Cantor’s Charles Duncan, Alethia Young and Eliana Merle.

Report can be found here